29
Lifecycle Management Through the Rx-to-OTC Switch
23. Sanofi and Lilly announce licensing agreement for
Cialis (tadalafil) OTC. [News Release.] 28 May
2-14. Eli Lilly website. https://investor.lilly.com/
news-releases/news-release-details/sanofi-and-lilly-an-
nounce-licensing-agreement-cialisr-tadalafil. Accessed
24 June 2021.
24. Op cit 5.
25. Op cit 5.
26. Op cit 5.
27. Op cit 5.
28. Analysis of Agreement Containing Consent Orders
to aid Public Comment. In the Matter of Johnson and
Johnson and Pfizer Inc. File No. 061-0220, Docket No.
C-4180. https://www.ftc.gov/sites/default/files/docu-
ments/cases/2006/12/0610220analysis.pdf. Accessed 24
June 2021.
29. Boehringer Ingelheim Corporation Announces
Agreement To Acquire Zantac(R) From Johnson and
Johnson and Pfizer Inc. For $509.5M. [News Release.]
Published 13 October 2006. https://www.biospace.com/
article/releases/boehringer-ingelheim-corporation-an-
nounces-agreement-to-acquire-zantac-r-from-johnson-
and-johnson-and-pfizer-inc-for-509-5m-/. Accessed
24 June 2021.
30. Palmer E. Zantac, generics ordered off the market
after FDA finds they’re a ticking time bomb. 1 April
2020. Fierce Pharma. https://www.fiercepharma.com/
manufacturing/zantac-and-generics-ordered-off-mar-
ket-by-fda-as-find-it-a-ticking-time-bomb. Accessed
24 June 2021.
31. Symphony IRI Latest 52 Week Period Ending 14 July
2019.
32. Pratt C. Three Blockbuster Drugs that Changed
the Market. 16 January 2017. Biotech Investing
News. https://investingnews.com/daily/
life-science-investing/pharmaceutical-invest-
ing/3-blockbuster-drugs-changed-the-market/.
Accessed 24 June 2021.
33. Freudenheim M. War on Heartburn Heats Up With
Over-the-Counter Blitz. The New York Times.
Published 8 September 1995.
34. Smithkline Beecham v. Johnson and Johnson-Merck,
906 F. Supp. 178 (S.D.N.Y. 1995). Justia US Law.
https://law.justia.com/cases/federal/district-courts/
FSupp/906/178/2126723/. Accessed 24 June 2021.
35. Xyzal website. https://www.xyzal.com/for-adults/.
Accessed 24 June 2021.
36. Draft Differin Leaflet. Reference ID 3956373. https://
www.accessdata.fda.gov/drugsatfda_docs/nda/2014/
205434Orig1s000SumR.pdf. Accessed 24 June 2021
37. Center For Drug Evaluation and Research Application
Number: 205434orig1s000. Summary Review. 23 July
2014. https://www.accessdata.fda.gov/drugsatfda_docs/
nda/2014/205434Orig1s000SumR.pdf. Accessed 6 July
2021.
38. Robbins R. A popular weight-loss pill was buoyed by
studies that understated its harms. 16 August 2016.
STAT website. https://www.statnews.com/2016/08/16/
weight-loss-pill-harms/. Accessed 24 June 2021.
39. Op cit 5.
40. Johnson CY. ‘Rapid release’ Tylenol gelcaps are
slower to dissolve than cheaper tablets, study finds.
14 November 2018. The Washington Post. https://
www.washingtonpost.com/health/2018/11/14/
rapid-release-tylenol-gelcaps-are-slower-dissolve-than-
cheaper-tablets-study-finds/. Accessed 24 June 2021.
41. DrugStore Management 2020-2021 Annual Drugstore
State of the Industry Report.
42. Voltaren Arthritis Pain and the Arthritis Foundation
Announce Multi-Year Partnership to Help People
Living with Osteoarthritis. [Press Release.] 13 April
2020. GSK website. https://us.gsk.com/en-us/media/
press-releases/voltaren-arthritis-pain-and-the-ar-
thritis-foundation-announce-multi-year-partner-
ship-to-help-people-living-with-osteoarthritis/.
Accessed 24 June 2021.
43. Berenson A. Next-Day Pill No Pot of Gold for Its
Maker. The New York Times. Published 25 August
2006.
44. Op cit 5.
45. Sanofi signs strategic deal for exclusive US over-
the-counter rights to Tamiflu in Flu Care [Press
Releases.] 23 July 2019. Sanofi website. https://
www.sanofi.com/en/media-room/press-relea
ses/2019/2019-07-23-07-00-00. Accessed 24 June
2021.
46. Perrigo Expands OTC Growth Strategy With Rx-To-
OTC Switch Licensing For Nasonex. [Press Release.] 9
August 2018. Perrigo website. https://investor.perrigo.
com/2018-08-09-Perrigo-Expands-OTC-Growth-
Strategy-With-Rx-To-OTC-Switch-Licensing-For-
Nasonex-R. Accessed 24 June 2021.
47. Op cit 23.
48. Pfizer to pay $250 million to AstraZeneca
for OTC Nexium marketing rights. 13
August 2012. Reuters website. https://www.
reuters.com/article/us-pfizer-astrazeneca/
pfizer-to-pay-250-million-to-astrazeneca-for-otc-nex-
ium-marketing-rights-idUSBRE87C11U20120813 .
Accessed 24 June 2021.
49. Santarus Inc. To License Heartburn Drug Rights To
Schering-Plough Corporation Santarus May Receive
Up To $65 Million. [Press Release.] 18 October 2006.
Biospace website. https://www.biospace.com/article/
releases/santarus-inc-to-license-heartburn-drug-rights-
to-schering-plough-corporation-b-santarus-b-may-re-
ceive-up-to-65-million-/. Accessed 24 June 2021.
50. Kar-Gupta S. Sanofi to buy U.S. group Chattem for
$1.9 billion. 21 December 2009. Reuters website.
https://www.reuters.com/article/us-sanofi-chattem/
sanofi-to-buy-u-s-group-chattem-for-1-9-billion-
idUSTRE5BK1GM20091221. Accessed 24 June 2021.
Lifecycle Management Through the Rx-to-OTC Switch
23. Sanofi and Lilly announce licensing agreement for
Cialis (tadalafil) OTC. [News Release.] 28 May
2-14. Eli Lilly website. https://investor.lilly.com/
news-releases/news-release-details/sanofi-and-lilly-an-
nounce-licensing-agreement-cialisr-tadalafil. Accessed
24 June 2021.
24. Op cit 5.
25. Op cit 5.
26. Op cit 5.
27. Op cit 5.
28. Analysis of Agreement Containing Consent Orders
to aid Public Comment. In the Matter of Johnson and
Johnson and Pfizer Inc. File No. 061-0220, Docket No.
C-4180. https://www.ftc.gov/sites/default/files/docu-
ments/cases/2006/12/0610220analysis.pdf. Accessed 24
June 2021.
29. Boehringer Ingelheim Corporation Announces
Agreement To Acquire Zantac(R) From Johnson and
Johnson and Pfizer Inc. For $509.5M. [News Release.]
Published 13 October 2006. https://www.biospace.com/
article/releases/boehringer-ingelheim-corporation-an-
nounces-agreement-to-acquire-zantac-r-from-johnson-
and-johnson-and-pfizer-inc-for-509-5m-/. Accessed
24 June 2021.
30. Palmer E. Zantac, generics ordered off the market
after FDA finds they’re a ticking time bomb. 1 April
2020. Fierce Pharma. https://www.fiercepharma.com/
manufacturing/zantac-and-generics-ordered-off-mar-
ket-by-fda-as-find-it-a-ticking-time-bomb. Accessed
24 June 2021.
31. Symphony IRI Latest 52 Week Period Ending 14 July
2019.
32. Pratt C. Three Blockbuster Drugs that Changed
the Market. 16 January 2017. Biotech Investing
News. https://investingnews.com/daily/
life-science-investing/pharmaceutical-invest-
ing/3-blockbuster-drugs-changed-the-market/.
Accessed 24 June 2021.
33. Freudenheim M. War on Heartburn Heats Up With
Over-the-Counter Blitz. The New York Times.
Published 8 September 1995.
34. Smithkline Beecham v. Johnson and Johnson-Merck,
906 F. Supp. 178 (S.D.N.Y. 1995). Justia US Law.
https://law.justia.com/cases/federal/district-courts/
FSupp/906/178/2126723/. Accessed 24 June 2021.
35. Xyzal website. https://www.xyzal.com/for-adults/.
Accessed 24 June 2021.
36. Draft Differin Leaflet. Reference ID 3956373. https://
www.accessdata.fda.gov/drugsatfda_docs/nda/2014/
205434Orig1s000SumR.pdf. Accessed 24 June 2021
37. Center For Drug Evaluation and Research Application
Number: 205434orig1s000. Summary Review. 23 July
2014. https://www.accessdata.fda.gov/drugsatfda_docs/
nda/2014/205434Orig1s000SumR.pdf. Accessed 6 July
2021.
38. Robbins R. A popular weight-loss pill was buoyed by
studies that understated its harms. 16 August 2016.
STAT website. https://www.statnews.com/2016/08/16/
weight-loss-pill-harms/. Accessed 24 June 2021.
39. Op cit 5.
40. Johnson CY. ‘Rapid release’ Tylenol gelcaps are
slower to dissolve than cheaper tablets, study finds.
14 November 2018. The Washington Post. https://
www.washingtonpost.com/health/2018/11/14/
rapid-release-tylenol-gelcaps-are-slower-dissolve-than-
cheaper-tablets-study-finds/. Accessed 24 June 2021.
41. DrugStore Management 2020-2021 Annual Drugstore
State of the Industry Report.
42. Voltaren Arthritis Pain and the Arthritis Foundation
Announce Multi-Year Partnership to Help People
Living with Osteoarthritis. [Press Release.] 13 April
2020. GSK website. https://us.gsk.com/en-us/media/
press-releases/voltaren-arthritis-pain-and-the-ar-
thritis-foundation-announce-multi-year-partner-
ship-to-help-people-living-with-osteoarthritis/.
Accessed 24 June 2021.
43. Berenson A. Next-Day Pill No Pot of Gold for Its
Maker. The New York Times. Published 25 August
2006.
44. Op cit 5.
45. Sanofi signs strategic deal for exclusive US over-
the-counter rights to Tamiflu in Flu Care [Press
Releases.] 23 July 2019. Sanofi website. https://
www.sanofi.com/en/media-room/press-relea
ses/2019/2019-07-23-07-00-00. Accessed 24 June
2021.
46. Perrigo Expands OTC Growth Strategy With Rx-To-
OTC Switch Licensing For Nasonex. [Press Release.] 9
August 2018. Perrigo website. https://investor.perrigo.
com/2018-08-09-Perrigo-Expands-OTC-Growth-
Strategy-With-Rx-To-OTC-Switch-Licensing-For-
Nasonex-R. Accessed 24 June 2021.
47. Op cit 23.
48. Pfizer to pay $250 million to AstraZeneca
for OTC Nexium marketing rights. 13
August 2012. Reuters website. https://www.
reuters.com/article/us-pfizer-astrazeneca/
pfizer-to-pay-250-million-to-astrazeneca-for-otc-nex-
ium-marketing-rights-idUSBRE87C11U20120813 .
Accessed 24 June 2021.
49. Santarus Inc. To License Heartburn Drug Rights To
Schering-Plough Corporation Santarus May Receive
Up To $65 Million. [Press Release.] 18 October 2006.
Biospace website. https://www.biospace.com/article/
releases/santarus-inc-to-license-heartburn-drug-rights-
to-schering-plough-corporation-b-santarus-b-may-re-
ceive-up-to-65-million-/. Accessed 24 June 2021.
50. Kar-Gupta S. Sanofi to buy U.S. group Chattem for
$1.9 billion. 21 December 2009. Reuters website.
https://www.reuters.com/article/us-sanofi-chattem/
sanofi-to-buy-u-s-group-chattem-for-1-9-billion-
idUSTRE5BK1GM20091221. Accessed 24 June 2021.